Ji S, Ji N
Front Oncol. 2025; 15:1481621.
PMID: 39931088
PMC: 11807812.
DOI: 10.3389/fonc.2025.1481621.
Leon-Gomez P, Romero V
Front Microbiol. 2025; 15:1515258.
PMID: 39911706
PMC: 11794528.
DOI: 10.3389/fmicb.2024.1515258.
Sturt A, Omar T, Hansingo I, Kamfwa P, Bustinduy A, Kelly H
BMC Womens Health. 2025; 25(1):2.
PMID: 39754189
PMC: 11697648.
DOI: 10.1186/s12905-024-03514-0.
Palomino-Vizcaino G, Banuelos-Villegas E, Alvarez-Salas L
Int J Mol Sci. 2024; 25(23.
PMID: 39684702
PMC: 11641362.
DOI: 10.3390/ijms252312991.
Plisko O, Zodzika J, Jermakova I, Pcolkina K, Prusakevica A, Liepniece-Karele I
PLoS One. 2024; 19(11):e0313004.
PMID: 39527583
PMC: 11554082.
DOI: 10.1371/journal.pone.0313004.
The characteristics of high-risk HPV-negative cervical cancer: a systematic review and meta-analysis.
Lou J, Guo F
Front Oncol. 2024; 14:1452834.
PMID: 39445063
PMC: 11496078.
DOI: 10.3389/fonc.2024.1452834.
Treatment with Epigallocatechin Gallate, Folic Acid, Vitamin B12, and Hyaluronic Acid Decreases HPV Positivity in Women Attending Regional Screening in Puglia.
Tinelli A, Gustapane S, Licchelli M, Coluccia A, Panese G, Proietti S
Microorganisms. 2024; 12(9).
PMID: 39338571
PMC: 11434421.
DOI: 10.3390/microorganisms12091897.
Split crRNA with CRISPR-Cas12a enabling highly sensitive and multiplexed detection of RNA and DNA.
Chen Y, Wang X, Zhang J, Jiang Q, Qiao B, He B
Nat Commun. 2024; 15(1):8342.
PMID: 39333528
PMC: 11436650.
DOI: 10.1038/s41467-024-52691-x.
Identification of E3 ubiquitin ligase-associated prognostic genes and construction of a prediction model for uterine cervical cancer based on bioinformatics analysis.
Yan Z, Yu J, Wang S, Wen W, Xin M, Li X
Discov Oncol. 2024; 15(1):395.
PMID: 39217222
PMC: 11365898.
DOI: 10.1007/s12672-024-01271-y.
Human papillomavirus molecular prevalence in south China and the impact on vaginal microbiome of unvaccinated women.
Wang T, Li W, Cai M, Ji S, Wang Y, Huang N
mSystems. 2024; 9(9):e0073824.
PMID: 39120153
PMC: 11407003.
DOI: 10.1128/msystems.00738-24.
HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-3.
Huang F, He L, Li W, Huang X, Zhang T, Muaibati M
Infect Agent Cancer. 2024; 19(1):36.
PMID: 39118158
PMC: 11308599.
DOI: 10.1186/s13027-024-00600-8.
Association between dyslipidemia and cervical intraepithelial neoplasia: A case-control study in south-western Uganda.
Ssedyabane F, Randall T, Ngonzi J, Kajabwangu R, Namuli A, Muhumuza J
Afr J Lab Med. 2024; 13(1):2374.
PMID: 39114748
PMC: 11304215.
DOI: 10.4102/ajlm.v13i1.2374.
FRETting about CRISPR-Cas Assays: Dual-Channel Reporting Lowers Detection Limits and Times-to-Result.
Lesinski J, Khosla N, Paganini C, Verberckmoes B, Vermandere H, deMello A
ACS Sens. 2024; 9(7):3616-3624.
PMID: 38978209
PMC: 11287743.
DOI: 10.1021/acssensors.4c00652.
Counteracting HPV Cervical and Anal Infection through Dietary Supplementation of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid: Clinical Case Reports.
Calcagno M, Incocciati B, Di Fraia L, Unfer V
J Clin Med. 2024; 13(12).
PMID: 38930126
PMC: 11204999.
DOI: 10.3390/jcm13123597.
The prevalence and genotype distribution of high-risk human papillomaviruses among women in Xianning, China.
Qiu B, Jiang N, Jiang J, Mao X, Wang X
Virol J. 2024; 21(1):140.
PMID: 38890675
PMC: 11186159.
DOI: 10.1186/s12985-024-02413-y.
Complexation of sgRNA and Cas12a Improves the Performance of a One-Pot RPA-CRISPR-Cas12 Assay.
Lesinski J, Moragues T, Mathur P, Shen Y, Paganini C, Bezinge L
Anal Chem. 2024; 96(25):10443-10450.
PMID: 38864271
PMC: 11210716.
DOI: 10.1021/acs.analchem.4c01777.
TMErisk score: A tumor microenvironment-based model for predicting prognosis and immunotherapy in patients with head and neck squamous cell carcinoma.
Li Y, Pan X, Luo W, Gamalla Y, Ma Z, Zhou P
Heliyon. 2024; 10(11):e31877.
PMID: 38845978
PMC: 11152963.
DOI: 10.1016/j.heliyon.2024.e31877.
Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology.
Ssedyabane F, Niyonzima N, Nambi Najjuma J, Birungi A, Atwine R, Tusubira D
SAGE Open Med. 2024; 12:20503121241252265.
PMID: 38764539
PMC: 11100407.
DOI: 10.1177/20503121241252265.
The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
Ullah A, Jiao W, Shen B
Cell Mol Biol Lett. 2024; 29(1):73.
PMID: 38745115
PMC: 11094955.
DOI: 10.1186/s11658-024-00591-9.
Human Papillomavirus Carcinogenicity and the Need of New Perspectives: Thoughts from a Retrospective Analysis on Human Papillomavirus Outcomes Conducted at the Hospital University of Bari, Apulia, Italy, between 2011 and 2022.
Del Prete R, Nesta D, Triggiano F, Lorusso M, Garzone S, Vitulano L
Diagnostics (Basel). 2024; 14(9).
PMID: 38732382
PMC: 11083870.
DOI: 10.3390/diagnostics14090968.